NCT06958315View on ClinicalTrials.gov

Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Atherosclerotic Vascular DiseaseHeterozygous Familial Hypercholesterolemia
Interventions
OTHER

Inclisiran

This is an observational study, there is no treatment allocation.

Trial Locations (7)

14004

RECRUITING

Novartis Investigative Site, Córdoba

18014

RECRUITING

Novartis Investigative Site, Granada

21005

RECRUITING

Novartis Investigative Site, Huelva

23007

RECRUITING

Novartis Investigative Site, Jaén

26006

RECRUITING

Novartis Investigative Site, Logroño

35010

RECRUITING

Novartis Investigative Site, Las Palmas de Gran Canaria

41009

RECRUITING

Novartis Investigative Site, Seville

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY